Healthcare resource use and indirect costs associated with migraine in Italy: results from the My Migraine Voice survey-Reference-Cited by-同舟云学术

Healthcare resource use and indirect costs associated with migraine in Italy: results from the My Migraine Voice survey

Published:2021-01-01 Issue:1 Volume:24 Page:717-726
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Martelletti Paolo¹^ORCID,Schwedt Todd J.²,Vo Pamela³,Ritrovato Daniela⁴,Reilly Margaret C.⁵,Naclerio Mariantonietta⁴,Ranjan Pallavi⁶,Kleebach Joern⁷,Joshi Parth⁶

Affiliation:

1. Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy

2. Mayo Clinic, Phoenix, Arizona, USA

3. Global Patient Access, Novartis Pharma AG, Basel, Switzerland

4. HEOR, Novartis Farma SpA, Origgio, Italy

5. Reilly Associates, New York, USA

6. Novartis Business Services, Hyderabad, India

7. Ipsos SA, Basel, Switzerland

Funder

Novartis Pharma AG

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2021.1925557

Reference51 articles.

1. Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participants

2. Migraine is first cause of disability in under 50s: will health politicians now take notice?

3. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

4. An Epidemiological Study to Assess Migraine Prevalence in a Sample of Italian Population Presenting to Their GPs

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute treatment of migraine: quantifying the unmet need through real-world data in Italy;Neurological Sciences;2024-03-27

2. The Role of the Combination Paracetamol/Caffeine in Treatment of Acute Migraine Pain: A Narrative Review;Pain and Therapy;2024-03-06

3. Comorbidity of migraine and fibromyalgia in patients with cluster headache: psychological burden and healthcare resource utilization. A cross-sectional study;Journal of Oral & Facial Pain and Headache;2024

4. Outcome measures for migraine: Measuring the impact of migraine and results of migraine treatment;Handbook of Clinical Neurology;2024

5. Annual indirect costs savings in patients with episodic or chronic migraine: a post-hoc analysis of phase 3 galcanezumab clinical trials in the United States;Journal of Medical Economics;2023-01-20